Do molecular tests really differentiate malignant IPMNS from benign?
نویسندگان
چکیده
منابع مشابه
Do molecular tests really differentiate malignant IPMNS from benign?
Bournet et al. have questioned the role of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) plus KRAS and GNAS mutations in malignant intraductal papillary mucinous neoplasms (IPMNs) of the pancreas in this issue of Endoscopy International Open [1]. Bournet et al. claimed that testing for KRAS mutations in cystic fluid improved the accuracy of results for cytopathologic diagnosis o...
متن کاملImmunophenotypic markers to differentiate between benign and malignant melanocytic lesions.
BACKGROUND/AIMS The authors investigated the expression of S100A1, S100A6, S100B, MelanA, and CEA in conjunctival naevi, primary acquired melanosis (PAM), conjunctival melanoma, and uveal melanoma in order to assess their potential usefulness in the pathological differential diagnosis of these entities. METHODS Paraffin embedded sections of 18 conjunctival naevi, 14 PAM, 16 conjunctival melan...
متن کاملTo differentiate benign from malignant thyroid nodule comparison of sonography with FNAC findings
OBJECTIVES To evaluate the diagnostic accuracy of sonography and Fine Needle Aspiration Cytology (FNAC). METHODOLOGY This follow-up study was approved by review board and conducted at Endocrine Clinic and Radiology Department of Imam Reza, Kermanshah. The patients were diagnosed to have thyroid nodule examined by FNA and Sonography suspicious malignant cases underwent surgery. RESULTS were en...
متن کاملA weighted scoring system to differentiate malignant liposarcomas from benign lipomas.
PURPOSE To construct a scoring system to differentiate malignant liposarcomas from benign lipomas by comparing their clinical and magnetic resonance imaging (MRI) features. METHODS Clinical and MRI features of 33 women and 33 men aged 17 to 83 (mean, 53) years who underwent resection of malignant liposarcomas (n=32) or benign lipomas (n=34) were reviewed. RESULTS The 5 strongest predictors ...
متن کاملDiffusivity measurements differentiate benign from malignant lesions in patients with peripheral neuropathy or plexopathy.
BACKGROUND AND PURPOSE Peripheral nerve disorders caused by benign and malignant primary nerve sheath tumors, infiltration or compression of nerves by metastatic disease, and postradiation neuritis demonstrate overlapping features on conventional MR imaging but require vastly different therapeutic approaches. We characterize and compare diffusivities of peripheral nerve lesions in patients unde...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Endoscopy International Open
سال: 2016
ISSN: 2364-3722,2196-9736
DOI: 10.1055/s-0042-121004